Activity of isoenzymes A and B of N-acetyl-β-glucosaminidase in renal cancer tissue
Journal Title: Współczesna Onkologia - Year 2006, Vol 10, Issue 10
Abstract
In Poland, renal cancer makes up 3-4% of all malignant tumours. Lysosomal glycosidases take part in renal tissue destruction. The exoglycosidases degrade the oligosaccharide chains of glycoconjugates (glycoproteins, proteoglycans and glycolipids). N-acetyl-β-glucosaminidase (E.C.3.2.1.52) (HEX) is an acid lysosomal exoglycosidase which releases N-acetylglucosamine (GlcNAc) and N-acetylgalactosamine (GalNAc) residues from the non-reducing ends of oligosaccharide chains of glycoconjugates (glycoproteins, glycolipids, proteoglycans). HEX is a glycoprotein composed of two polypeptide chains a and β. The chains are present in pairs in three possible combinations: isoenzyme A-αβ, isoenzyme B-ββ and isoenzyme S-αα. Isoenzymes A and B demonstrate the highest activity in the tissues; however, the ratio of isoenzymes A/B is different in various tissues. In the natural oligosaccharides, HEX hydrolyzes the b glycoside bond of N-acetylhexosamine with other sugars. The enzyme reacts with artificial substrates such as derivatives of hexosamines with p-nitrophenol and umbelliferone. To determine the activity of isoenzymes A and B in renal tumour and neighbouring macroscopically normal renal tissue in polyacrylamide gel after isoelectrofocusing, we used a-naphtyl-AS- -BI-N-acetyl-b-glucosaminide as a substrate. Electrofocusing is an electrophoretic method of protein separation in polyacrylamide gel which uses the migration of molecules in a pH gradient that is formed after applying an electric field to an ampholyte mixture. The aim of the study was quantitative determination of N-acetyl-β-D hexosaminidase isoenzymes activity by using two methods: colorimetric and electrophoretic and two different substrates. Materials: Renal specimens harvested from 30 patients during surgery due to renal cancer were used for the study. Results: In cancerous and normal human renal tissues, isoenzyme A of N-acetyl-b-D hexosaminidase showed statistically higher specific activity, in comparison to isoenzyme B, after determination of both isoenzymes by two different methods. Conclusion: Determination of HEX isoenzyme activity using the colorimetric method may be considered as a valuable diagnostic marker in renal diseases. The results of HEX isoenzyme activity determination by colorimetric and electrophoretic method are compatible, although for routine determinations the colorimetric method is recommended as the electrofocusing is more technically difficult and more expensive than the colorimetric one.
Authors and Affiliations
Małgorzata Borzym-Kluczyk, Ewa Olszewska, Sławomir Szajda, Barbara Darewicz, Krzysztof Zwierz
Keywords
Related Articles
- EP ID EP102035
- DOI -
- Views 54
- Downloads 0
Przednia resekcja odbytnicy – wybrane aspekty jakości życia chorych
Rak jelita grubego jest narastającym problemem nie tylko onkologicznym, ale przede wszystkim zdrowotnym współczesnego społeczeństwa w Polsce i na świecie. Badania nad jakością życia w chorobach przewlekłych są cennym źró...
Wyniki leczenia chorych na złośliwego międzybłoniaka opłucnej w materiale Centrum Onkologii w Krakowie
Celem pracy jest przedstawienie wyników leczenia chorych na złośliwego międzybłoniaka opłucnej w Centrum Onkologii w Krakowie. Materiał: W latach 1965–2003 w Centrum Onkologii w Krakowie leczono 63 chorych z powodu złoś...
Treatment of bone metastases in breast cancer patients
Bone metastases are a major problem in the clinical management of patients with breast cancer. With prolongation of survival, the challenge is to improve the quality of the patient’s remaining life. The treatment of me...
Antygen raka płaskonabłonkowego (SCC) w diagnostyce i monitorowaniu leczenia chorych na raka szyjki macicy
Antygen raka płaskonabłonkowego (SCC – squamous cell carcinoma antigen) jest pierwszym markerem w raku szyjki macicy. SCC należy do rodziny inhibitorów proteaz serynowych. Podwyższone stężenie SCC występuje w rakach pł...
Przerzuty do ośrodkowego układu nerwowego u chorych na rozsianego raka piersi leczonych trastuzumabem
Amplifikacja genu HER2 i/lub nadekspresja receptora HER2 występuje w 20–30 proc. inwazyjnych raków piersi i w 60 proc. raków śródprzewodowych. U chorych na inwazyjnego raka piersi zaburzenia genu HER2 związane są z bar...